Share:
  • Title:EMPEROR-Reduced: Empagliflozin benefits in HF patients irrespective of diabetes | Milton Packer
  • Duration: 6:28
  • Views: 9.7K
  • Uploaded: 3 years ago

Similar Songs

EMPEROR-Reduced: Time for a change in the HF guidelines? | Miles Fisher▶️ 5:09
Emperor-reduced: Time For A Change In The Hf Guidelines? | Miles Fisher 303 views • 3 years ago
EMPEROR-Preserved: Diabetes medication becomes first effective HFpEF therapy | Stefan Anker▶️ 8:27
Emperor-preserved: Diabetes Medication Becomes First Effective Hfpef Therapy | Stefan Anker 1.9K views • 3 years ago
Empagliflozin Retains Benefits in ‘True’ HFpEF Patients▶️ 5:10
Empagliflozin Retains Benefits In ‘true’ Hfpef Patients 1.3K views • 2 years ago
Professor Milton Packer - 'Heart failure – are there limits to anti-diabetic therapy with SGLT2'▶️ 38:55
Professor Milton Packer - 'heart Failure – Are There Limits To Anti-diabetic Therapy With Sglt2' 14K views • 5 years ago
EMPEROR-Preserved: The implications for primary care | Kevin Fernando▶️ 4:43
Emperor-preserved: The Implications For Primary Care | Kevin Fernando 1.1K views • 3 years ago
ESC 2020 Discussion: The EMPEROR-Reduced Study — Dr Milton Packer & Dr Harriette Van Spall▶️ 23:49
Esc 2020 Discussion: The Emperor-reduced Study — Dr Milton Packer & Dr Harriette Van Spall 3.7K views • 3 years ago
New Hope for Heart Failure patients- A gamechanger arrives▶️ 6:50
New Hope For Heart Failure Patients- A Gamechanger Arrives 75K views • 4 years ago
EHJ Today - The EMPA-REG OUTCOME Trial▶️ 11:19
Ehj Today - The Empa-reg Outcome Trial 6.4K views • 8 years ago
A Tale of Salt and Sugar: SGLT2 Inhibitors in Cardiovascular Disease▶️ 1:06:15
A Tale Of Salt And Sugar: Sglt2 Inhibitors In Cardiovascular Disease 9.2K views • 2 years ago
Time to reconsider the person with shortness of breath: EMPEROR-Preserved▶️ 38:55
Time To Reconsider The Person With Shortness Of Breath: Emperor-preserved 943 views • 2 years ago
EMPEROR PRESERVED trial. Empagliflozin in HFpEF patients.▶️ 6:41
Emperor Preserved Trial. Empagliflozin In Hfpef Patients. 1.8K views • 2 years ago
EASD2021 EMPEROR-Reduced Trial what doesit meaning for the future?▶️ 10:13
Easd2021 Emperor-reduced Trial What Doesit Meaning For The Future? 104 views • 2 years ago
EMPULSE: The ‘missing link’ for empagliflozin in heart failure | Adriaan Voors▶️ 5:21
Empulse: The ‘missing Link’ For Empagliflozin In Heart Failure | Adriaan Voors 2.2K views • 2 years ago
SGLT2 inhibition in type 1 diabetes | Lori Berard▶️ 1:53
Sglt2 Inhibition In Type 1 Diabetes | Lori Berard 325 views • 6 years ago
AHA 2021: EMPEROR-Preserved: Empagliflozin, Health Status, & QoL in Patients With HFpEF | Dr Butler▶️ 2:38
Aha 2021: Emperor-preserved: Empagliflozin, Health Status, & Qol In Patients With Hfpef | Dr Butler 378 views • 2 years ago
Heart Failure Spotlight: Jardiance® (empagliflozin) tablets: The Impact of EMPA-REG OUTCOME▶️ 30:29
Heart Failure Spotlight: Jardiance® (empagliflozin) Tablets: The Impact Of Empa-reg Outcome 20K views • 2 years ago
Empagliflozin in Heart Failure with a Preserved Ejection Fraction▶️ 13:17
Empagliflozin In Heart Failure With A Preserved Ejection Fraction 4.7K views • 2 years ago
Role of SGLT2 inhibitor, Empagliflozin in the glycaemic control in Diabetes▶️ 34:19
Role Of Sglt2 Inhibitor, Empagliflozin In The Glycaemic Control In Diabetes 3.1K views • 2 years ago
Time to reconsider the person with shortness of breath: EMPEROR-Preserved▶️ 1:08
Time To Reconsider The Person With Shortness Of Breath: Emperor-preserved 53 views • 2 years ago
JARDIANCE for Heart Failure and Diabetes: An IN-DEPTH Summary▶️ 10:31
Jardiance For Heart Failure And Diabetes: An In-depth Summary 25K views • 1 year ago
Protocols for Safe Use of SGLT2i and GLP1RA in the Hospital Setting▶️ 50:30
Protocols For Safe Use Of Sglt2i And Glp1ra In The Hospital Setting 3K views • 4 years ago